Mind Medicine, Inc.

1325 Airmotive Way Ste 175A, Reno, Nevada, United States$507.3M

Clinical Trials

6 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

38.5%

Phase 2

30.8%

Phase 3

30.8%

Trial Status Distribution

Active, not recruiting

46.1%

Completed

38.5%

Recruiting

15.4%

Clinical Trials

Trials sponsored by this organization (13)

A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

Phase 2

Completed

interventional

Aug 2022198 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations

Mind Medicine, Inc.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (13)

A Phase 2A Trial of DT402 for Autism Spectrum Disorder

A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)

Phase I trial: MM-120-101

Phase I trial MM-402-101

Phase I trial MM-120-102

A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

Approvals

News